After six trials, neither Merck & Co. nor plaintiffs attorneys have captured the upper hand in the litigation blizzard that followed the withdrawal of the pain medication Vioxx, experts say. A Texas ruling against Merck on Friday ties the score at three wins for plaintiffs and three for the company. What has emerged from the trials so far is a basic footprint of the two sides' approaches. The stakes are staggering: Analysts estimate Merck's potential liability could reach $50 billion.
April 25, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
After millions in expenses and hundreds of hours of court time in six separate trials, neither Merck & Co. nor plaintiffs attorneys have captured the upper hand in the litigation blizzard that followed the withdrawal of the pain medication Vioxx, experts say.
On Friday, jurors in south Texas found Merck liable for the death of Leonel Garza, a 71-year-old man who suffered heart attack after taking Vioxx for one month. That ties the score at three wins for plaintiffs and three for Merck.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
